Beijing Biostar Pharmaceuticals Co., Ltd. (HKG:2563)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
3.860
-0.190 (-4.69%)
May 28, 2026, 3:53 PM HKT

HKG:2563 Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,4071,7837,182---
Market Cap Growth
-75.16%-75.18%----
Enterprise Value
9011,2116,639---
Last Close Price
3.864.8919.70---
PS Ratio
37.9048.0293.92---
PB Ratio
1.902.408.54---
P/TBV Ratio
1.932.458.68---
EV/Sales Ratio
24.2732.6186.82---
Debt / Equity Ratio
0.000.000.000.000.000.00
Net Debt / Equity Ratio
-0.68-0.68-0.72-0.79-0.84-0.85
Net Debt / EBITDA Ratio
3.503.503.552.773.932.81
Net Debt / FCF Ratio
2.902.903.733.226.548.95
Asset Turnover
0.040.040.090.080.040.07
Inventory Turnover
0.070.070.330.680.330.29
Quick Ratio
7.537.537.5413.5314.8545.76
Current Ratio
8.338.338.8314.4815.5647.70
Return on Equity (ROE)
-18.04%-18.04%-18.99%-23.84%-17.72%-28.90%
Return on Assets (ROA)
-10.34%-10.34%-12.59%-15.93%-12.84%-18.74%
Return on Capital Employed (ROCE)
-19.80%-19.80%-20.40%-29.70%-22.20%-31.10%
Earnings Yield
-10.39%-8.20%-2.13%---
FCF Yield
-12.41%-9.80%-2.27%---
Buyback Yield / Dilution
-4.11%-4.11%-0.19%---
Source: S&P Global Market Intelligence. Standard template. Financial Sources.